Updated:
Wellington Partners
Wellington Partners is a leading European venture capital firm investing in early- and growth-stage life science companies. Since 1998 it has supported...
Wellington Partners
Wellington Partners is a leading European venture capital firm investing in early- and growth-stage life science companies. Since 1998 it has supported entrepreneurs turning breakthrough technologies into global businesses across Germany, Europe and beyond. It focuses on sectors including Therapeutics, Medical Devices, Diagnostics, Digital Health and Industrial Biotechnology.
General information
Firm type
Private Equity
Year founded
1998
AUM
~€800 million
Location
Region
Europe
Country
Germany
City
Munich, Bavaria
Corporate office
Türkenstraße 5, 80333 Munich, Germany
Additional offices
Seidengasse 16, 8001 Zurich, Switzerland
Principals
Dr. Rainer Strohmenger
Managing Partner
Dr. Johannes Fischer
Managing Partner
Dr. Varun Gupta
Partner
Harald Keller
Managing Partner, CFO
Ernst Mannheimer
Managing Partner, Legal Counsel
Sabine Kannegiesser
Partner
Dr. Regina Hodits
Venture Advisor
Sector focus
Frequently asked questions
Does Wellington Partners invest outside of Europe?
Wellington states it focuses on companies from Germany, Europe, and beyond. Its Zurich office and portfolio companies like Polares Medical, which is U.S.-focused, indicate the firm will back European-origin companies that pursue global regulatory pathways, including FDA approval in the United States.
How is Wellington Partners' current fund different from its predecessors?
WPLS V, the firm's fifth fund, closed at EUR 210 million, which the firm reports is more than double the volume of its predecessor. It was considerably oversubscribed and remains focused on biotechnology and medical technology.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: